Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Scientists Decode Genome Of Cholera Strain From 1849

New York Times: With Help of Victims From 1849, Scientists Decode Early Strain of Cholera “Using bits of human intestine stored in a Philadelphia medical museum in 1849, scientists have decoded the genes of an early form of cholera, the deadly diarrheal disease that first swept the globe just a…

5 Actions To Promote Global Health In 2014

Devex: 5 ways to accelerate global health in 2014 Allan Pamba, director of public engagement and access initiatives at GSK “…If we’re to cement the progress already made in helping people live healthier lives — regardless of where they live — we must start making last year’s conversations a reality.…

Volunteer Physician Discusses Importance Of Funding For NTD Research

The Global Health Technologies Coalition’s “Breakthroughs” blog interviews volunteer physician Brian D’Cruz, who has worked with Médecins Sans Frontières (MSF) in Congo Brazzaville and Central African Republic. D’Cruz discusses the “urgent need for USAID to support R&D for neglected tropical diseases (NTDs) like sleeping sickness,” and he says that with…

Implementation Models For Dissemination Of Mental Health Research Needed

“In recent years, growing interest and awareness has resulted in global mental health finally stepping out of the narrow field of psychiatry and beginning to occupy space in public health discourse,” Julia Beart, head of business development for the U.K. charity Basic Needs, and Shoba Raja, director of policy and…

WHO, Partners Launch Malaria Vaccine Technology Roadmap

“The [WHO] and its partners Thursday announced a new goal to license vaccines by 2030 that would sharply reduce malaria cases and eventually eliminate the disease,” VOA News reports (DeCapua, 11/14). The updated 2013 Malaria Vaccine Technology Roadmap “comes in addition to the original 2006 roadmap’s goal of having a…

Researchers Report P. Vivax Malaria Evolving To Become More Infectious

“A common type of malaria that used to be powerless to infect certain groups of Africans is becoming more potent, putting tens of millions of people at risk, scientists said Friday,” Agence France-Presse/GlobalPost reports (11/15). “Now roughly 95 percent of people in sub-Saharan Africa — where the malaria burden is…

Financial Times Examines Implications Of Controversy Over Indian HPV Vaccination Study

The Financial Times examines how the deaths of seven female participants of a study on the cost and feasibility of incorporating human papillomavirus (HPV) vaccines “into India’s public sector immunization program” has affected opinions of drug trials in the country. “[T]he program to vaccinate 14,000 adolescent girls from poor families…

Lancet Releases ‘Tuberculosis 2014’ Series

In recognition of World TB Day, The Lancet published Tuberculosis 2014, a series featuring papers from The Lancet Infectious Diseases and The Lancet Respiratory Medicine “discussing topics ranging from host-directed therapies and vaccines, extremely drug-resistant tuberculosis, and new anti-tuberculosis drugs, [and] highlighting not only past successes, but also the challenges…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.